Aaron Pelta
Corporate Officer/Principal presso MORPHIC HOLDING, INC.
Posizioni attive di Aaron Pelta
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MORPHIC HOLDING, INC. | Corporate Officer/Principal | 01/01/2019 | - |
Storia della carriera di Aaron Pelta
Precedenti posizioni note di Aaron Pelta
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| X4 Pharmaceuticals (Austria) GmbH | Corporate Officer/Principal | 01/08/2016 | 01/03/2019 |
| AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | 18/06/2015 | 01/11/2015 |
Formazione di Aaron Pelta
| Tuck School of Business at Dartmouth | Masters Business Admin |
| Tufts University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Austria | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MORPHIC HOLDING, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
| X4 Pharmaceuticals (Austria) GmbH |
- Borsa valori
- Insiders
- Aaron Pelta
- Esperienza
